Curis | CRIS - Trade Creditors


Curis reported $5.61M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Alaunos Therapeutics USD 400K 213K Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Bayer EUR 6.59B 496M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
CSL USD 3.17B 290M Dec/2025
Curis USD 5.61M 1.52M Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Exelixis USD 24.15M 5.47M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Merck USD 3.86B 541M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.71B 219M Mar/2026
Takeda JPY 491.34B 23.75B Mar/2026
TG Therapeutics USD 148.84M 41.34M Mar/2026
Verastem USD 12.45M 2.56M Dec/2025
Xoma USD 2.65M 1.52M Sep/2025